source
- FDA advisory panel to decide on compounding of synthetic peptides amid safety concernsThe FDA advisory committee is meeting to consider whether compounding pharmacies should be allowed to manufacture seven specific synthetic peptides. Use of these peptides has grown in the United St…
- BeOne invests $300 million in New Jersey plant, adding small-molecule capacity and 120 jobsBeOne Medicines announced a $300 million investment to expand its manufacturing campus in Hopewell, New Jersey. The expansion will include a three‑story, 145,000‑square‑foot building for small‑mol…